BioAge Labs, Inc. — Company profile
Healthcare · Drug Manufacturers - Specialty & Generic · United States
Last price 5.94 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 272.63M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. The company’s technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging. Its lead product candidate includes BGE-102, an orally available brain-penetrant small-molecule NLRP3 inhibitor which is in Phase 1 clinical trail for the treatment of atherosclerotic cardiovascular disease, as well as for the treatment of diabetic macular edema and geographic atrophy; and develops APJ agonists for obesity, including programs targeting both oral and parenteral administration. The company has collaboration agreement with Novartis Pharma AG to identify and validate novel therapeutic drug targets by investigating the biological mechanisms that drive diseases related to aging and mediate. BioAge Labs, Inc. was incorporated in 2015 and is headquartered in Emeryville, California.
Details
| Name | BioAge Labs, Inc. |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Employees | 62 |
| Founded | 2015 |
| Ipo Date | 2024-09-26 |
| Ceo | Kristen Fortney |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 18.00 |
| Isin | US09077V1008 |
| Cusip | 09077V100 |
| Cik | 1709941 |
| Sic | 2834 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Dr. Kristen Fortney Ph.D. | Co-Founder, Chief Executive Officer, President, Treasurer, Secretary and Director |
| Dr. Eric Morgen M.D. | Co-Founder, Chief Operating Officer and Director |
| Dr. Paul D. Rubin M.D. | Chief Medical Officer and Executive Vice President of Research |
| Dr. Dov A. Goldstein M.B.A., M.D. | Chief Financial Officer |
| Shane Barton CPA | Senior Vice President of Finance and Accounting |
| Rusty Montgomery Ph.D. | Senior Vice President of Research |
| Julie Gammelgard | Senior Vice President of People |
| Dr. Peng Leong M.B.A., Ph.D. | Chief Business Officer and Therapeutic Area Head of Brain Aging |
| BJ Sullivan Ph.D. | Chief Strategy Officer |
| Ann C. Neale RN BSN | Chief Development Officer |
Contact
| Address | 5885 Hollis Street, Suite 370, EmeryVille, California 94608, United States |
| Phone | 510 806 1445 |
| Website | https://bioagelabs.com |